Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-1-25
pubmed:abstractText
The development of novel yeast strains with increased tolerance toward inhibitors in lignocellulosic hydrolysates is highly desirable for the production of bio-ethanol. Weak organic acids such as acetic and formic acids are necessarily released during the pretreatment (i.e. solubilization and hydrolysis) of lignocelluloses, which negatively affect microbial growth and ethanol production. However, since the mode of toxicity is complicated, genetic engineering strategies addressing yeast tolerance to weak organic acids have been rare. Thus, enhanced basic research is expected to identify target genes for improved weak acid tolerance.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-10919795, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-11229906, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-11693915, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-12510742, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-12570990, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-15066826, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-15184173, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-15630585, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-16222531, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-16332810, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-16439654, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-16652391, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-16713243, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-16915647, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-16977466, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-17033882, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-17050014, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-17227047, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-17524590, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-17665194, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-17846724, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-18302314, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-18310411, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-18478400, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-18538626, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-18772282, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-19237442, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-19416101, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-19446584, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-19517136, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-19572128, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-19653633, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-19695948, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-19707752, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-2851900, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-6684148, http://linkedlifedata.com/resource/pubmed/commentcorrection/21219616-8534086
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1475-2859
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2
pubmed:dateRevised
2011-7-20
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Metabolic pathway engineering based on metabolomics confers acetic and formic acid tolerance to a recombinant xylose-fermenting strain of Saccharomyces cerevisiae.
pubmed:affiliation
Organization of Advanced Science and Technology, Kobe University, 1-1 Rokkodai, Nada, Kobe, 657-8501, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't